Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000604691 | SCV000725518 | likely benign | not specified | 2017-12-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000880901 | SCV001024029 | benign | Glycogen storage disease due to muscle and heart glycogen synthase deficiency | 2023-11-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000880901 | SCV003800106 | likely benign | Glycogen storage disease due to muscle and heart glycogen synthase deficiency | 2022-04-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003953063 | SCV004767631 | likely benign | GYS1-related disorder | 2021-02-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |